AI Tool to Slash Pharma Development Costs by Predicting Drug Trial Outcomes
A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...
Doctors may face suspension in NMC probe over pharma-sponsored trips
This was in violation of the UCPMP rules, which regulate interactions between pharmaceutical companies and HCPs and prohibit ...
cnbctv185h
Torrent Pharma Q3 Results: Profit rises 13.5%, announces interim dividend of ₹26 per share
Torrent Pharma, which is also the flagship company of the Torrent Group, announced an interim dividend of ₹26 per share for ...
Will Donald Trump turn out to be a bitter pill for Indian pharma stocks again?
The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
Takeda-backed Ascentage Pharma targets $1.8 bln valuation in US IPO
Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...
Benchmarks trade with moderate cuts; pharma shares decline
IST, the barometer index, the S&P BSE Sensex, shed 172.42 points or 0.23% to 76,348.14. The Nifty 50 index lost 69.15 points or 0.30% to 23,136.20.
Texas, other states reach $7.4 billion deal with Purdue Pharma over opioids crisis
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement with Texas and 14 other states to ...
Recursion Pharmaceuticals (RXRX): Industrializing Drug Discovery with AI Amid J.P. Morgan’s ‘Neutral’ Outlook
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
Patent expiry of key drugs to open up extra market space for Indian pharma manufacturers
The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...
Purdue Pharma, Sacklers reach $7.4 billion national opioid settlement
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...